New Triple-Drug attack shows promise against common lymphoma
NCT ID NCT04450173
First seen Apr 21, 2026 · Last updated May 24, 2026 · Updated 7 times
Summary
This study tests a combination of three drugs (obinutuzumab, ibrutinib, and venetoclax) in 40 people with untreated follicular lymphoma, a slow-growing blood cancer. The goal is to see if the combination works better than each drug alone at shrinking tumors and controlling the disease. Participants receive all three drugs for a set period, and researchers monitor how many achieve complete remission and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRADE 3A FOLLICULAR LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California Davis Comprehensive Cancer Center
Sacramento, California, 95817, United States
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
-
University of California, San Diego
San Diego, California, 92037, United States
-
University of California, San Francisco (UCSF) Fresno
Fresno, California, 93701, United States
Conditions
Explore the condition pages connected to this study.